Cellular basis of uraemic cardiomyopathy: a role for erythropoietin?
about
Anemia and associated clinical outcomes in patients with heart failure due to reduced left ventricular systolic function.Diabetes mellitus: channeling care through cellular discoveryImpact of reduced kidney function on cardiopulmonary fitness in patients with systolic heart failure.Novel avenues of drug discovery and biomarkers for diabetes mellitus.
P2860
Cellular basis of uraemic cardiomyopathy: a role for erythropoietin?
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Cellular basis of uraemic cardiomyopathy: a role for erythropoietin?
@en
Cellular basis of uraemic cardiomyopathy: a role for erythropoietin?
@nl
type
label
Cellular basis of uraemic cardiomyopathy: a role for erythropoietin?
@en
Cellular basis of uraemic cardiomyopathy: a role for erythropoietin?
@nl
prefLabel
Cellular basis of uraemic cardiomyopathy: a role for erythropoietin?
@en
Cellular basis of uraemic cardiomyopathy: a role for erythropoietin?
@nl
P2093
P2860
P356
P1476
Cellular basis of uraemic cardiomyopathy: a role for erythropoietin?
@en
P2093
Anne-Marie L Seymour
David Semple
Katie Smith
P2860
P304
P356
10.1093/EURJHF/HFP093
P577
2009-08-01T00:00:00Z